Torsten Passie
Corporate Officer/Principal chez Hannover Medical School
Profil
Torsten Passie was the founder of Entheogen Corp.
which was founded in 2010, where he held the title of Chief Scientific Officer & Director.
Currently, he is the Laboratory Director & Assistant Professor at Hannover Medical School.
Dr. Passie has a graduate degree from the University of Hannover and a doctorate degree from Hannover Medical School.
Postes actifs de Torsten Passie
| Sociétés | Poste | Début |
|---|---|---|
| Hannover Medical School | Corporate Officer/Principal | 10/02/2011 |
Anciens postes connus de Torsten Passie
| Sociétés | Poste | Fin |
|---|---|---|
Entheogen Corp.
 Entheogen Corp. BiotechnologyHealth Technology Entheogen Corp. manufactures biopharmaceutical products. Its 2-Bromo-LSD, known as BOL-148 provides treatment for cluster headache. The firm offers treatment for chronic headache like migraine and cluster headaches. The company was founded by John Halpern, Torsten Passie and Ari Mello in 2010 and is headquartered in Stow, MA. | Fondateur | - |
Formation de Torsten Passie
| Hannover Medical School | Doctorate Degree |
| University of Hannover | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Entheogen Corp.
Entheogen Corp. BiotechnologyHealth Technology Entheogen Corp. manufactures biopharmaceutical products. Its 2-Bromo-LSD, known as BOL-148 provides treatment for cluster headache. The firm offers treatment for chronic headache like migraine and cluster headaches. The company was founded by John Halpern, Torsten Passie and Ari Mello in 2010 and is headquartered in Stow, MA. | Health Technology |
